Targeting and killing the Ever-Challenging ulcer bug

Area of Science:

• Nanotechnology
• Microbiology
• Gastroenterology

Background:

• Helicobacter pylori infections are a persistent challenge, contributing to gastric cancer due to ineffective antibiotic delivery.
• Current treatments struggle to achieve adequate antibiotic concentrations at the infection site.

Purpose of the Study:

• To develop amoxicillin-loaded lipid nanoparticles for enhanced H. pylori treatment.
• To evaluate the nanoparticles' targeting, bacteria-killing, and gastrointestinal barrier-overcoming capabilities.
• To assess the potential of a stomach-retention floating system for nanoparticle delivery.

Main Methods:

• Development of lipid nanoparticles using DOPE, Tween®80, and linolenic acid.
• Evaluation of bacterial targeting and adhesion inhibition using imaging flow cytometry and cell models.
• Assessment of antibacterial efficacy through time-kill kinetics, SEM, and membrane permeability studies.
• Testing in a novel in vitro gastrointestinal infection model and incorporation into a floating system.

Main Results:

• Nanoparticles demonstrated effective bacterial targeting and inhibition of adhesion to gastric cells.
• An antibiotic-free strategy was shown to kill H. pylori, confirmed by membrane permeability studies.
• The nanosystem successfully overcame physical and chemical gastrointestinal barriers.
• Incorporation into a floating system increased potential stomach retention time.

Conclusions:

• The developed amoxicillin-loaded lipid nanoparticles represent an effective nanosystem for combating H. pylori infections.
• The study introduces innovative tools: an in vitro infection model and a nanoparticle-based floating system with broader applications.